Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
This study has been completed.
Study NCT00330733 Information provided by Department of Veterans Affairs
First Received on May 26, 2006. Last Updated on October 28, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atherosclerosis
Cardiovascular Disease
Inflammation
Insulin Resistance
NIDDM
Additional conditions recognized in this trial
Cardiovascular Diseases
Diabetes Mellitus, Type 2
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Metabolic Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Salsalate
Placebo
Additional drug interventions recognized in this trial
Insulin
Salicylsalicylic acid
Sodium Salicylate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Department of Veterans Affairs
Joslin Diabetes Center
Back to top of Main Content
